Who owns G1 Therapeutics?
- CUSIP Number: 3621lq109
Tip: Access positions for across all investors
Analyze quarterly positions in G1 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of G1 Therapeutics stock
Who bought or sold G1 Therapeutics this quarter?
There are no current stakeholders of G1 Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of G1 Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Raymond James & Associates | Jun 2024 | 798k | $1.8M |
| Readystate Asset Management | Jun 2024 | 199k | $455k |
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | Jun 2024 | 193k | $439k |
| FinTrust Capital Advisors | Jun 2024 | 101k | $230k |
| Raymond James Financial Services Advisors | Jun 2024 | 37k | $84k |
| Planning Capital Management Corp | Jun 2024 | 320.00 | $729.984000 |